AZN vs SBH · P/E 28, $288.38B cap vs P/E 7.2, rev $3.70B
AstraZeneca PLC (AZN) versus Sally Beauty Holdings Inc (SBH) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Sally Beauty Holdings Inc (SBH) is a specialty retail company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported SBH revenue for 2025-09-30 was $3.70B. Net income was $195.9M. SBH currently screens at market cap $1.25B and trailing P/E 7.2.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SBH currently screens at market cap $1.25B and trailing P/E 7.2.
Not investment advice. Open the AZN and SBH stock pages for the full models.
Not investment advice.